|
Market Closed -
Nasdaq
21:00:00 04/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 220.83 USD | -1.64% |
|
+1.07% | +25.48% |
| 06:53am | Eisai, Biogen Secure China's Nod for Self-Injection Version of Leqembi | MT |
| 09-03 | Piper Sander Adjusts Biogen Price Target to $245 From $225, Maintains Overweight Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
- Stock Market
- Stocks
- BIIB Stock
- Charts Biogen Inc.
- Total Return chart
Select your edition
All financial news and data tailored to specific country editions
